Tolerability with no loss of efficacy after overnight conversion from immediate-release ropinirole to an extended-release formulation - ropinirole CR - in restless legs syndrome

被引：0

|

作者：

Isaacson, S.

Castiglia, M.

Hodge, R.

机构：

来源：

PARKINSONISM & RELATED DISORDERS | 2007年 / 13卷

关键词：

D O I：

10.1016/S1353-8020(08)70529-7

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S74 / S75

页数：2

相关论文

共 50 条

[21] Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity
Stoehrer, M.
Muertz, G.
Kramer, G.
Warnack, W.
Primus, G.
Jinga, V.
Manu-Marin, A.
Calomfirescu, N.
Strugala, G.
SPINAL CORD, 2013, 51 (05) : 419 - 423
[22] Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity
M Stöhrer
G Mürtz
G Kramer
W Warnack
G Primus
V Jinga
A Manu-Marin
N Calomfirescu
G Strugala
Spinal Cord, 2013, 51 : 419 - 423
[23] Ropinirole CR extended release demonstrates improvements from the first night of treatment in patients with moderate-to-severe primary restless legs syndrome (RLS)
Ferguson, James M.
Bogan, Richard
Earl, Nancy
NEUROLOGY, 2007, 68 (12) : A256 - A256
[24] Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score ≥ 24 points -: data from the ropinirole clinical trial programme
Giorgi, Luigi
Ritchie, Sally Y.
Kirsch, Jeffrey M.
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 1867 - 1877
[25] A 52-week, open-label study to assess the long-term tolerability of ropinirole CR extended release tablets in subjects with restless legs syndrome (RLS)
Hill-Zabala, C.
Bogan, R.
Lee, D.
Lomax, M.
MOVEMENT DISORDERS, 2008, 23 (01) : S363 - S364
[26] Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: A randomized trial
Olsson, AG
Pauciullo, P
Soska, V
Luley, C
Pieters, RE
Broda, G
Palacios, B
CLINICAL THERAPEUTICS, 2001, 23 (01) : 45 - +
[27] Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients
Choi, David
Thaker, Sarang
West-Thielke, Patricia
Elmasri, Annesti
Chan, Christine
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (08) : 1124 - 1128
[28] Ropinirolle CR - A new extended-release formulation - Reduces symptom severity in patients with primary restless legs syndrome (RLS)
Ferguson, James M.
Becker, Philip
Williams, Nicola J.
NEUROLOGY, 2007, 68 (12) : A255 - A256
[29] Patient satisfaction with ropinirole CR, a once-daily extended-release treatment for moderate-to-severe primary restless legs syndrome results from a 12-week pivotal study
Becker, P.
Castiglia, M.
SLEEP, 2007, 30 : A285 - A285
[30] LEVEL/DOSE RATIO (LDR) OF TACROLIMUS IN PATIENTS WITH STABLE LIVER TRANSPLANT BEFORE AND AFTER CONVERSION FROM IMMEDIATE-RELEASE TACROLIMUS TO EXTENDED-RELEASE FORMULATION
Mesones-Jimenez, R.
Hernandez-Sanchez, J. M.
de Cos, M. A.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 44 - 44

← 1 2 3 4 5 →